Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:IBM NASDAQ:NVDA NYSE:RH OTCMKTS:RHHBY OTCMKTS:RHHVF NASDAQ:RXRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBMInternational Business Machines$301.93-1.2%$245.61$212.34▼$332.46$287.26B0.6711.45 million shs9.58 million shsNVDANVIDIA$218.66+1.8%$202.84$138.83▼$236.54$5.20T2.22166.81 million shs168.18 million shsRHRH$152.84+0.3%$132.78$106.30▼$257.00$2.88B1.91813,789 shs586,321 shsRHHBYRoche$51.57+5.2%$50.84$37.51▼$60.85$312.16B0.52.47 million shs1.45 million shsRHHVFRoche$420.59+8.2%$404.18$300.15▼$490.33N/AN/A18,289 shs652 shsRXRXRecursion Pharmaceuticals$3.80+9.5%$3.30$2.77▼$7.18$1.84B1.0417.85 million shs38.57 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBMInternational Business Machines-1.45%+14.26%+31.84%+16.94%+13.79%NVDANVIDIA+1.82%+2.06%+11.29%+22.96%+54.07%RHRH+0.04%+2.37%+23.74%+7.47%-14.42%RHHBYRoche+5.24%-1.51%+1.44%-6.90%+26.40%RHHVFRoche+8.19%+0.75%+4.21%-4.21%+27.68%RXRXRecursion Pharmaceuticals+9.51%+10.47%+12.76%+9.83%-22.61%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBMInternational Business Machines$301.93-1.2%$245.61$212.34▼$332.46$287.26B0.6711.45 million shs9.58 million shsNVDANVIDIA$218.66+1.8%$202.84$138.83▼$236.54$5.20T2.22166.81 million shs168.18 million shsRHRH$152.84+0.3%$132.78$106.30▼$257.00$2.88B1.91813,789 shs586,321 shsRHHBYRoche$51.57+5.2%$50.84$37.51▼$60.85$312.16B0.52.47 million shs1.45 million shsRHHVFRoche$420.59+8.2%$404.18$300.15▼$490.33N/AN/A18,289 shs652 shsRXRXRecursion Pharmaceuticals$3.80+9.5%$3.30$2.77▼$7.18$1.84B1.0417.85 million shs38.57 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBMInternational Business Machines-1.45%+14.26%+31.84%+16.94%+13.79%NVDANVIDIA+1.82%+2.06%+11.29%+22.96%+54.07%RHRH+0.04%+2.37%+23.74%+7.47%-14.42%RHHBYRoche+5.24%-1.51%+1.44%-6.90%+26.40%RHHVFRoche+8.19%+0.75%+4.21%-4.21%+27.68%RXRXRecursion Pharmaceuticals+9.51%+10.47%+12.76%+9.83%-22.61%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIBMInternational Business Machines 2.70Moderate Buy$304.170.74% UpsideNVDANVIDIA 3.00Buy$305.3839.66% UpsideRHRH 2.10Hold$175.1314.59% UpsideRHHBYRoche 2.45Hold$51.50-0.14% DownsideRHHVFRoche 0.00N/AN/AN/ARXRXRecursion Pharmaceuticals 2.20Hold$8.10113.16% UpsideCurrent Analyst Ratings BreakdownLatest RXRX, IBM, RH, RHHBY, RHHVF, and NVDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2026IBMInternational Business Machines Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy6/3/2026IBMInternational Business Machines Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/2/2026IBMInternational Business Machines CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$285.00 ➝ $375.006/2/2026NVDANVIDIA William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform6/2/2026IBMInternational Business Machines WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$350.006/2/2026NVDANVIDIA Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$270.006/1/2026IBMInternational Business Machines BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageEqual Weight ➝ Overweight$350.006/1/2026IBMInternational Business Machines BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$350.006/1/2026NVDANVIDIA DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$300.005/29/2026IBMInternational Business Machines WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$320.005/28/2026IBMInternational Business Machines Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIBMInternational Business Machines$68.91B4.12$16.92 per share17.84$35.03 per share8.62NVDANVIDIA$215.94B24.51$4.81 per share45.46$8.08 per share27.06RHRH$3.44B0.84$20.19 per share7.57$3.23 per share47.32RHHBYRoche$76.45B4.30$3.79 per share13.61$7.18 per share7.18RHHVFRocheN/AN/AN/AN/AN/AN/ARXRXRecursion Pharmaceuticals$74.68M26.96N/AN/A$2.14 per share1.78Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIBMInternational Business Machines$10.59B$11.3126.7022.603.1715.61%37.23%7.49%7/22/2026 (Estimated)NVDANVIDIA$120.07B$6.5333.4920.120.5262.97%96.94%72.16%N/ARHRH$124.79M$6.3124.2214.882.343.63%-567.82%2.62%6/11/2026 (Estimated)RHHBYRoche$15.55BN/AN/A14.694.03N/AN/AN/A7/23/2026 (Estimated)RHHVFRocheN/A$10.8138.91N/AN/AN/AN/AN/AN/ARXRXRecursion Pharmaceuticals-$644.76M-$1.20N/AN/AN/A-842.95%-54.33%-40.60%8/4/2026 (Estimated)Latest RXRX, IBM, RH, RHHBY, RHHVF, and NVDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/11/2026Q1 2027RHRH-$2.0903N/AN/AN/A$792.55 millionN/A5/20/2026Q1 2027NVDANVIDIA$1.76$1.87+$0.11$2.39$78.42 billion$81.62 billion5/6/2026Q1 2026RXRXRecursion Pharmaceuticals-$0.30-$0.22+$0.08-$0.22$15.78 million$6.47 million4/22/2026Q1 2026IBMInternational Business Machines$1.81$1.91+$0.10$1.28$15.60 billion$15.92 billion3/31/2026Q4 2026RHRH$2.21$1.53-$0.68$1.46$873.48 million$842.62 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthIBMInternational Business Machines$6.762.24%+0.61%59.77%30 YearsNVDANVIDIA$0.040.02%+14.87%0.61%1 YearsRHRHN/AN/AN/AN/AN/ARHHBYRoche$0.971.88%N/AN/AN/ARHHVFRoche$7.801.85%N/A72.16%N/ARXRXRecursion PharmaceuticalsN/AN/AN/AN/AN/ALatest RXRX, IBM, RH, RHHBY, RHHVF, and NVDA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2026NVDANVIDIAquarterly$0.250.46%6/4/20266/4/20266/26/20264/22/2026IBMInternational Business Machinesquarterly$1.692.95%5/8/20265/8/20266/10/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIBMInternational Business Machines1.750.800.76NVDANVIDIA0.043.442.85RHRH51.281.190.31RHHBYRoche0.721.381.12RHHVFRocheN/AN/AN/ARXRXRecursion Pharmaceuticals0.015.475.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIBMInternational Business Machines58.96%NVDANVIDIA65.27%RHRH90.17%RHHBYRocheN/ARHHVFRoche29.01%RXRXRecursion Pharmaceuticals89.06%Insider OwnershipCompanyInsider OwnershipIBMInternational Business Machines0.27%NVDANVIDIA3.94%RHRH26.90%RHHBYRocheN/ARHHVFRocheN/ARXRXRecursion Pharmaceuticals8.43%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIBMInternational Business Machines286,800939.89 million937.35 millionOptionableNVDANVIDIA42,00024.20 billion23.25 billionOptionableRHRH7,23018.90 million13.82 millionOptionableRHHBYRoche103,2496.37 billionN/ANot OptionableRHHVFRoche103,605N/AN/ANot OptionableRXRXRecursion Pharmaceuticals400529.91 million485.23 millionOptionableRXRX, IBM, RH, RHHBY, RHHVF, and NVDA HeadlinesRecent News About These CompaniesRecursion (RXRX) Climbs 9.5% Ahead of Next Week’s Business Updates4 hours ago | finance.yahoo.comBlake Borgeson Sells 30,000 Shares of Recursion Pharmaceuticals (NASDAQ:RXRX) StockJune 4 at 7:34 PM | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Trading 12.5% Higher - Here's What HappenedJune 4 at 2:17 PM | marketbeat.comWhy Recursion Pharmaceuticals (RXRX) Is Up 9.5% After AI Pipeline Progress And Stronger-Than-Expected Q1 ResultsJune 4 at 1:17 PM | finance.yahoo.comRecursion’s AI Drug Pipeline Progress Tests Investor Patience And ValuationJune 4 at 8:16 AM | finance.yahoo.comThree AI Healthcare Stocks Chart Distinct Growth TrajectoriesJune 2 at 11:35 PM | nai500.comNRecursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?June 2 at 6:34 PM | fool.comRecursion to Participate in Upcoming Investor ConferencesJune 2 at 8:32 AM | finance.yahoo.comRecursion to Participate in Upcoming Investor ConferencesJune 2 at 8:00 AM | globenewswire.comLingotto Investment Management LLP Buys 1,255,980 Shares of Recursion Pharmaceuticals, Inc. $RXRXJune 2 at 6:55 AM | marketbeat.comRecursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing RulesMay 29, 2026 | finance.yahoo.comRecursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing RulesMay 29, 2026 | globenewswire.comVerge, following trial failure, rebrands its AI drug discovery ambitionsMay 27, 2026 | biopharmadive.comBRecursion Pharmaceuticals (NASDAQ:RXRX) Trading 8.9% Higher - Here's WhyMay 27, 2026 | marketbeat.comRecursion Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:RXRX)May 27, 2026 | marketbeat.comRecursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?May 25, 2026 | fool.comRecursion Pharmaceuticals (RXRX) Hits 52-Week Low; Is It In Oversold Territory?May 24, 2026 | insidermonkey.comRecursion Pharmaceuticals (RXRX) Hits 52-Week Low; Is It In Oversold Territory?May 24, 2026 | finance.yahoo.comA Look At Recursion Pharmaceuticals (RXRX) Valuation As Mixed Signals Emerge On Future Growth ProspectsMay 23, 2026 | finance.yahoo.comMorgan Stanley Raises its Price Target on Recursion (RXRX)May 22, 2026 | finance.yahoo.comRecursion Pharmaceuticals (NASDAQ:RXRX) Sets New 52-Week Low - Here's What HappenedMay 19, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCatching Falling Knives: Is It Time to Buy These Beaten-Down Stocks?By Dan Schmidt | May 11, 2026Overextended, e.l.f. Beauty Is Primed to Rebound in Back HalfBy Thomas Hughes | May 22, 2026Oklo Stock Could Be Ready for Another Massive RunBy Thomas Hughes | May 14, 2026MP Materials Is Quietly Building a Rare Earth PowerhouseBy Leo Miller | May 12, 2026Quantum Computing's Commercial Breakout Has ArrivedBy Jeffrey Neal Johnson | May 27, 2026RXRX, IBM, RH, RHHBY, RHHVF, and NVDA Company DescriptionsInternational Business Machines NYSE:IBM$301.93 -3.70 (-1.21%) Closing price 06/4/2026 03:59 PM EasternExtended Trading$299.63 -2.31 (-0.76%) As of 06/4/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.NVIDIA NASDAQ:NVDA$218.66 +3.91 (+1.82%) Closing price 06/4/2026 04:00 PM EasternExtended Trading$216.32 -2.34 (-1.07%) As of 06/4/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.RH NYSE:RH$152.84 +0.39 (+0.25%) Closing price 06/4/2026 03:59 PM EasternExtended Trading$152.57 -0.27 (-0.18%) As of 06/4/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.RH, together with its subsidiaries, operates as a retailer in the home furnishings market. The company offers products in various categories, including furniture, lighting, textiles, bathware, décor, outdoor and garden, baby, child, and teen furnishings. It provides its products through rh.com, rhbabyandchild.com, rhteen.com, rhmodern.com, and waterworks.com online channels, as well as operates RH Galleries, RH outlet stores, RH Guesthouse, and Waterworks showrooms in the United States, Canada, the United Kingdom, and Germany. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was incorporated in 2011 and is headquartered in Corte Madera, California.Roche OTCMKTS:RHHBY$51.57 +2.57 (+5.24%) As of 06/4/2026 03:59 PM EasternRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.Roche OTCMKTS:RHHVF$420.59 +31.84 (+8.19%) As of 06/4/2026 03:47 PM EasternRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.Recursion Pharmaceuticals NASDAQ:RXRX$3.80 +0.33 (+9.51%) Closing price 06/4/2026 04:00 PM EasternExtended Trading$3.79 -0.01 (-0.26%) As of 06/4/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand Medtronic Bottoms, Healthy Rebound Ahead From Runway to Riches: Victoria's Secret's New Look Coke's $10B India IPO Plan Pops the Top on Hidden Value Dell's AI Toll Bridge Is Paved with Record Margins The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker GitLab’s Price Recovery Gains Traction—Time to Get On Board? Ulta's Q1 Report Primes It for a Beauty of a Rebound Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
